Annual long term liabilities:
$22.89M+$1.12M(+5.16%)Summary
- As of today (September 19, 2025), VRDN annual total long term liabilities is $22.89 million, with the most recent change of +$1.12 million (+5.16%) on December 31, 2024.
- During the last 3 years, VRDN annual long term liabilities has risen by +$20.53 million (+871.15%).
- VRDN annual long term liabilities is now at all-time high.
Performance
VRDN Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$14.57M-$8.21M(-36.04%)Summary
- As of today (September 19, 2025), VRDN quarterly total long term liabilities is $14.57 million, with the most recent change of -$8.21 million (-36.04%) on June 30, 2025.
- Over the past year, VRDN quarterly long term liabilities has dropped by -$4.99 million (-25.52%).
- VRDN quarterly long term liabilities is now -36.76% below its all-time high of $23.04 million, reached on September 30, 2024.
Performance
VRDN quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VRDN Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.2% | -25.5% |
3 y3 years | +871.1% | +123.2% |
5 y5 years | +428.9% | +160.6% |
VRDN Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +871.1% | -36.8% | +124.0% |
5 y | 5-year | at high | +4107.7% | -36.8% | +3560.8% |
alltime | all time | at high | >+9999.0% | -36.8% | >+9999.0% |
VRDN Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $14.57M(-36.0%) |
Mar 2025 | - | $22.78M(-0.5%) |
Dec 2024 | $22.89M(+5.2%) | $22.89M(-0.7%) |
Sep 2024 | - | $23.04M(+17.8%) |
Jun 2024 | - | $19.56M(-9.9%) |
Mar 2024 | - | $21.72M(-0.2%) |
Dec 2023 | $21.77M(+226.0%) | $21.77M(-0.8%) |
Sep 2023 | - | $21.93M(+215.5%) |
Jun 2023 | - | $6.95M(+6.9%) |
Mar 2023 | - | $6.50M(-2.6%) |
Dec 2022 | $6.68M(+183.3%) | $6.68M(+2.3%) |
Jun 2022 | - | $6.53M(+205.5%) |
Mar 2022 | - | $2.14M(-9.3%) |
Dec 2021 | $2.36M(+333.3%) | $2.36M(+3.6%) |
Sep 2021 | - | $2.27M(-7.5%) |
Jun 2021 | - | $2.46M(+518.1%) |
Mar 2021 | - | $398.00K(-26.8%) |
Dec 2020 | $544.00K(-87.4%) | $544.00K(-87.1%) |
Sep 2020 | - | $4.23M(-24.3%) |
Jun 2020 | - | $5.59M(+65.0%) |
Mar 2020 | - | $3.39M(-21.7%) |
Dec 2019 | $4.33M | $4.33M(-17.7%) |
Sep 2019 | - | $5.26M(-15.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $6.20M(-13.1%) |
Mar 2019 | - | $7.13M(-11.6%) |
Dec 2018 | $8.07M(-19.9%) | $8.07M(-10.4%) |
Sep 2018 | - | $9.00M(-9.4%) |
Jun 2018 | - | $9.93M(-2.1%) |
Mar 2018 | - | $10.15M(+0.7%) |
Dec 2017 | $10.07M(>+9900.0%) | $10.07M(+544.9%) |
Sep 2017 | - | $1.56M(-24.2%) |
Jun 2017 | - | $2.06M(-18.3%) |
Mar 2017 | - | $2.52M(-10.6%) |
Dec 2016 | $0.00(-100.0%) | $2.82M(>+9900.0%) |
Sep 2016 | - | $2000.00(-75.0%) |
Jun 2016 | - | $8000.00(-42.9%) |
Mar 2016 | - | $14.00K(-72.0%) |
Dec 2015 | $24.00K(-78.0%) | - |
Sep 2015 | - | $50.00K(-34.2%) |
Jun 2015 | - | $76.00K(-26.2%) |
Mar 2015 | - | $103.00K(-5.5%) |
Dec 2014 | $109.00K(-57.9%) | $109.00K(>+9900.0%) |
Sep 2014 | - | $0.00(-100.0%) |
Jun 2014 | - | $62.50K(-75.9%) |
Dec 2013 | $259.00K(-58.3%) | $259.40K(-55.2%) |
Dec 2012 | $620.80K | - |
Dec 2012 | - | $578.80K |
FAQ
- What is Viridian Therapeutics, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Viridian Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of VRDN is $22.89M
What is the all time high annual long term liabilities for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual total long term liabilities is $22.89M
What is Viridian Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, VRDN annual total long term liabilities has changed by +$1.12M (+5.16%)
What is Viridian Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of VRDN is $14.57M
What is the all time high quarterly long term liabilities for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly total long term liabilities is $23.04M
What is Viridian Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, VRDN quarterly total long term liabilities has changed by -$4.99M (-25.52%)